SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001013594-19-000182
Filing Date
2019-02-14
Accepted
2019-02-14 15:57:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 14, 2019 catalystbio13ga-021419.htm SC 13G/A 111068
  Complete submission text file 0001013594-19-000182.txt   112622
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82442 | Film No.: 19605698
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 900 THIRD AVENUE SUITE 1100 NEW YORK NY 10022
Business Address 900 THIRD AVENUE SUITE 1100 NEW YORK NY 10022 (212) 213-7033
NEXTHERA CAPITAL LP (Filed by) CIK: 0001646343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A